-The Pioneer Hitting at UPA’s biggest flagship scheme Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA), Agriculture Ministry has criticised the scheme in it’s first ever Agriculture Survey saying that MGNREGA has led to double digit growth in wages annually in the last few years even exceeding the rate of inflation that prevailed during this period. The Agriculture Survey is compiled by the Agriculture Ministry as a precursor to Union Budget on...

-PTI India has an estimated 25 lakh gay population and about 7 per cent of them are HIV-infected, the government today told the Supreme Court. “The population of MSM (men who have sex with men) is estimated to be 25 lakh in India,” the government said in its affidavit filed in the court, citing figures of the National Aids Control programme. The affidavit, filed by the health ministry, said it is planning to...

In a landmark decision, India’s intellectual property office on Monday allowed Hyderabad-based Natco Pharma Ltd to make and sell a copycat version of German drug maker Bayer AG’s patented cancer treatment Nexavar. It’s the first time that an Indian company has been granted the so-called compulsory licence to market a generic version of a patented drug. The drug, patented by Bayer in India in 2008, is used in the treatment of...

-The Economic Times The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision.  The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...

-Reuters India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say.  On Monday, the Indian Patent Office effectively ended Bayer's monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug...